Details of the Drug-Related molecule(s) Interaction Atlas

General Information of Drug (ID: DMG62H1)

Drug Name
CereCRIB Drug Info
Synonyms
ACTID; Drug implant (analgesic), CytoTherapeutics; Bovine cell impant (pain, ECT), CytoTherapeutics; Bovine cell implant (pain, CRIB), CytoTherapeutics; Bovine cell impant (pain, ECT), CytoTherapeutics, AstraZeneca; Bovine cell implant (pain, CRIB), CytoTherapeutics, AstraZeneca
Indication
Disease Entry ICD 11 Status REF
Pain MG30-MG3Z Discontinued in Phase 2 [1]
Cross-matching ID
PubChem CID
16129718
TTD Drug ID
DMG62H1

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Approved Drug(s)
Download the Complete Related Drug List
Drug(s) Targeting Opioid receptor (OPR)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Methadone DMTW6IU Advanced cancer 2A00-2F9Z Approved [3]
Ketobemidone DMM3L6Z Pain MG30-MG3Z Approved [4]
Oxymorphone DM65AGJ Pain MG30-MG3Z Approved [5]
Dextropropoxyphene DM23HCX Pain MG30-MG3Z Approved [6]
Sufentanil DMU7YEL Analgesia MB40.8 Approved [7]
Naltrexone DMUL45H Alcohol dependence 6C40.2 Approved [8]
Levorphanol DMGS80V Pain MG30-MG3Z Approved [9]
Pentazocine DM1XBHS Pain MG30-MG3Z Approved [10]
Nalmefene DM4YWCZ Opioid dependence 6C43.2Z Approved [11]
Tilidine DMJW0VS Pain MG30-MG3Z Approved [12]
⏷ Show the Full List of 10 Drug(s)

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas
Download the Complete Interaction Atlas for Visualization in Cytoscape

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Opioid receptor (OPR) TTN4QDT NOUNIPROTAC Modulator [2]

References

1 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800007886)
2 US patent application no. 5,874,099, Methods for making immunoisolatary implantable vehicles with a biocompatible jacket and a biocompatible matrix core.
3 Methadone treatment and its dangers. Medicina (Kaunas). 2009;45(5):419-25.
4 The mu1 and mu2 opioid receptor binding of ketobemidone, norketobemidone and 3-dimethylamino-1,1-diphenylbutene. Pharmacol Toxicol. 1996 Aug;79(2):103-4.
5 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7094).
6 Retrospective diagnosis of an adverse drug reaction in a breastfed neonate: liquid chromatography-tandem mass spectrometry quantification of dextropropoxyphene and norpropoxyphene in newborn and maternal hair. J Anal Toxicol. 2008 Nov-Dec;39(9):787-9.
7 mu-opioid receptor-stimulated synthesis of reactive oxygen species is mediated via phospholipase D2. J Neurochem. 2009 Aug;110(4):1288-96.
8 An evaluation of mu-opioid receptor (OPRM1) as a predictor of naltrexone response in the treatment of alcohol dependence: results from the Combined Pharmacotherapies and Behavioral Interventions for Alcohol Dependence (COMBINE) study. Arch Gen Psychiatry. 2008 Feb;65(2):135-44.
9 Comparison of the effects of dextromethorphan, dextrorphan, and levorphanol on the hypothalamo-pituitary-adrenal axis. J Pharmacol Exp Ther. 2004 May;309(2):515-22.
10 Functional characterization of a sigma receptor and its gene expression by haloperidol. Nippon Yakurigaku Zasshi. 1999 Jul;114(1):61-8.
11 Unconditioned behavioral effects of the powerful kappa-opioid hallucinogen salvinorin A in nonhuman primates: fast onset and entry into cerebrospin... J Pharmacol Exp Ther. 2009 Feb;328(2):588-97.
12 Actions of tilidine and nortilidine on cloned opioid receptors. Eur J Pharmacol. 2005 Jan 4;506(3):205-8.